|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2017-10-11 08:30:02 CEST 2017-10-11 08:30:02 CEST Biohit Oyj - Managers' transactionsBiohit Oyj - Managers' TransactionsBiohit Oyj - Managers' Transactions, October 11, 2017 at 9:30 am. local time (EEST) Biohit Oyj has received the following notification.
Additional information:
CEO Semi Korpela, Biohit Oyj
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|